Garth Rapeport is the founder and CEO of Pulmocide, an innovative venture capital funded company that specialises in tackling prevalent, but hard-to-treat respiratory infections.
The company focuses on infections associated with life-threatening... complications that can have significant effects on patients’ quality of life. A unique biopharmaceutical company, Pulmocide Ltd is identifying and developing potent inhaled antifungal and antiviral medicines for life-threatening lung conditions. These include Invasive Aspergillus, RSV (respiratory syncytial virus), asthma and cystic fibrosis.
However, should you feel that a review is in violation of our guidelines, you can submit a request to have the review assessed by the ProvenExpert quality assurance team by using the following contact form.